Jun Nawata

947 total citations
23 papers, 745 citations indexed

About

Jun Nawata is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Jun Nawata has authored 23 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in Jun Nawata's work include Pulmonary Hypertension Research and Treatments (11 papers), Cardiovascular Function and Risk Factors (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Jun Nawata is often cited by papers focused on Pulmonary Hypertension Research and Treatments (11 papers), Cardiovascular Function and Risk Factors (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Jun Nawata collaborates with scholars based in Japan and Ireland. Jun Nawata's co-authors include Jun Demachi, Hiroaki Shimokawa, Yoshihiro Fukumoto, Kunio Shirato, K Saji, Jun Suzuki, Masahito Sakuma, Tohru Takahashi, Yutaka Kagaya and Hiroshi Fujita and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Hypertension and Respiratory Medicine.

In The Last Decade

Jun Nawata

23 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Nawata Japan 12 437 389 216 97 75 23 745
Niki Penner United States 9 536 1.2× 308 0.8× 164 0.8× 40 0.4× 70 0.9× 11 740
Diana M. Tabima United States 14 486 1.1× 462 1.2× 152 0.7× 127 1.3× 137 1.8× 31 848
Ekaterina Legchenko Germany 10 357 0.8× 230 0.6× 307 1.4× 57 0.6× 110 1.5× 20 737
Hans‐Peter Baum Germany 11 246 0.6× 140 0.4× 349 1.6× 42 0.4× 54 0.7× 24 657
Akihiko Karibe Japan 16 132 0.3× 896 2.3× 658 3.0× 132 1.4× 155 2.1× 23 1.5k
Ilonka Rohm Germany 15 93 0.2× 283 0.7× 135 0.6× 86 0.9× 79 1.1× 31 654
Suko Adiarto Indonesia 8 124 0.3× 295 0.8× 200 0.9× 101 1.0× 119 1.6× 35 609
Ngoc Nguyen Germany 13 196 0.4× 379 1.0× 151 0.7× 50 0.5× 132 1.8× 19 905
Koba Kupreishvili Netherlands 8 100 0.2× 563 1.4× 150 0.7× 55 0.6× 110 1.5× 13 836
Pedro Mendes‐Ferreira Portugal 12 266 0.6× 235 0.6× 145 0.7× 35 0.4× 74 1.0× 25 464

Countries citing papers authored by Jun Nawata

Since Specialization
Citations

This map shows the geographic impact of Jun Nawata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Nawata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Nawata more than expected).

Fields of papers citing papers by Jun Nawata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Nawata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Nawata. The network helps show where Jun Nawata may publish in the future.

Co-authorship network of co-authors of Jun Nawata

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Nawata. A scholar is included among the top collaborators of Jun Nawata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Nawata. Jun Nawata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujita, Hiroshi, Yoshihiro Fukumoto, K Saji, et al.. (2010). Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension. Heart and Vessels. 25(2). 144–149. 120 indexed citations
2.
Fukui, Shigefumi, Yoshihiro Fukumoto, Jun Suzuki, et al.. (2009). Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin–angiotensin system in hypertensive rats. Hypertension Research. 32(6). 472–480. 20 indexed citations
3.
Sakuma, Masahito, Jun Demachi, Jun Nawata, et al.. (2009). Long-Term Epoprostenol Therapy in Pulmonary Artery Hypertension. Circulation Journal. 73(3). 523–529. 6 indexed citations
4.
Fukumoto, Yoshihiro, Aya Takaki, Shunsuke Tawara, et al.. (2009). Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension. Circulation Journal. 73(9). 1731–1739. 124 indexed citations
5.
Fukui, Shigefumi, Yoshihiro Fukumoto, Jun Suzuki, et al.. (2008). Long-term Inhibition of Rho-kinase Ameliorates Diastolic Heart Failure in Hypertensive Rats. Journal of Cardiovascular Pharmacology. 51(3). 317–326. 49 indexed citations
6.
Sakuma, Masahito, Jun Demachi, Jun Nawata, et al.. (2008). Epoprostenol Infusion Therapy Changes Angiographic Findings of Pulmonary Arteries in Patients With Idiopathic Pulmonary Arterial Hypertension. Circulation Journal. 72(7). 1147–1151. 10 indexed citations
7.
Nawata, Jun, Tomohiro Tada, Huan Wang, et al.. (2008). Increased Static Pressure Promotes Migration of Vascular Smooth Muscle Cells: Involvement of the Rho-kinase Pathway. Journal of Cardiovascular Pharmacology. 51(1). 55–61. 14 indexed citations
8.
Sakuma, Masahito, Jun Demachi, Jun Suzuki, et al.. (2007). Proximal Pulmonary Artery Aneurysms in Patients with Pulmonary Artery Hypertension: Complicated Cases. Internal Medicine. 46(21). 1789–1793. 27 indexed citations
9.
Sakuma, Masahito, Jun Demachi, Jun Suzuki, et al.. (2007). Peripheral Pulmonary Artery Aneurysms in Patients with Pulmonary Artery Hypertension. Internal Medicine. 46(13). 979–984. 10 indexed citations
10.
Saji, K, Yoshihiro Fukumoto, Jun Suzuki, et al.. (2007). Colchicine, a Microtubule Depolymerizing Agent, Inhibits Myocardial Apoptosis in Rats. The Tohoku Journal of Experimental Medicine. 213(2). 139–148. 28 indexed citations
11.
Oikawa, Minako, Yutaka Kagaya, Hiroki Otani, et al.. (2005). Increased [18F]Fluorodeoxyglucose Accumulation in Right Ventricular Free Wall in Patients With Pulmonary Hypertension and the Effect of Epoprostenol. Journal of the American College of Cardiology. 45(11). 1849–1855. 205 indexed citations
12.
Saji, K, Masahito Sakuma, Jun Suzuki, et al.. (2005). Efficacy of Acute Inhalation of Nitric Oxide in Patients With Primary Pulmonary Hypertension Using Chronic Use of Continuous Epoprostenol Infusion. Circulation Journal. 69(3). 335–338. 5 indexed citations
13.
Sakuma, Masahito, Jun Demachi, Tohru Takahashi, et al.. (2005). Portopulmonary Hypertension. Circulation Journal. 69(11). 1386–1393. 5 indexed citations
14.
Nawata, Jun, et al.. (2005). Neutrophil survival-enhancing activity in sputum from patients with diffuse panbronchiolitis. Respiratory Medicine. 99(7). 910–917. 3 indexed citations
15.
Wang, Huan, Jun Nawata, Koichiro Sugimura, et al.. (2004). The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin–angiotensin system in vivo. Journal of Hypertension. 22(7). 1323–1332. 22 indexed citations
16.
Takahashi, Tohru, Masahito Sakuma, Jun Ikeda, et al.. (2002). Effects and Problems of Continuous Infusion of Epoprostenol for Patients with Primary Pulmonary Hypertension.. Internal Medicine. 41(10). 784–788. 4 indexed citations
17.
Kagaya, Yutaka, Nobumasa Ishide, Shuichi Kitada, et al.. (2001). Interaction between sarcomere and mitochondrial length in normoxic and hypoxic rat ventricular papillary muscles. Cardiovascular Pathology. 10(3). 125–132. 17 indexed citations
18.
Suzuki, Jun, Isao Ohno, Jun Nawata, et al.. (1999). Overexpression of Insulin-Like Growth Factor-I in Hearts of Rats with Isoproterenol-Induced Cardiac Hypertrophy. Journal of Cardiovascular Pharmacology. 34(5). 635–644. 11 indexed citations
19.
Suzuki, Jun, Shigeo Baba, Isao Ohno, et al.. (1999). Immunohistochemical Analysis of Platelet-derived Growth Factor-B Expression in Myocardial Tissues In Hypertrophic Cardiomyopathy. Cardiovascular Pathology. 8(4). 223–231. 7 indexed citations
20.
Suzuki, Masakazu, et al.. (1998). Patient background of the Pokemon phenomenon: Questionnaire studies in multiple pediatric clinics. Pediatrics International. 40(6). 550–554. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niki Penner Breakdown of academic impact, for papers by Diana M. Tabima Breakdown of academic impact, for papers by Ekaterina Legchenko Breakdown of academic impact, for papers by Hans‐Peter Baum Breakdown of academic impact, for papers by Akihiko Karibe Breakdown of academic impact, for papers by Ilonka Rohm Breakdown of academic impact, for papers by Suko Adiarto Breakdown of academic impact, for papers by Ngoc Nguyen Breakdown of academic impact, for papers by Koba Kupreishvili Breakdown of academic impact, for papers by Pedro Mendes‐Ferreira
Rankless by CCL
2026